Thermo Fisher Scientific has introduced Invitrogen UltraComp eBeads Spectral Unmixing Beads to improve accuracy in spectral and conventional flow cytometry. These beads help researchers more accurately separate overlapping fluorescent signals, making it easier to distinguish many cell types quickly, track rare cells and achieve consistent performance across experiments.
Researchers who use flow cytometry as a tool for analyzing cellular phenotypes and functions require deeper insights into cells to better understand disease and discover targeted therapies. Spectral and high-parameter flow cytometry can provide a more comprehensive view of many cell types, but current solutions can lead to false positives and negatives, as well as background interference that limits analysis. UltraComp eBeads behave like real cells, reduce autofluorescence and enhance fluorochrome signal clarity, leading to more precise results.
This next-generation solution sets a new standard in compensation bead performance by offering support for the broadest variety of species on the market. UltraComp eBeads can bind with mouse, rat, hamster, rabbit or recombinant human antibodies.
The product is designed for research use by immunologists and immuno-oncologists from academic institutions, pharmaceutical and biotechnology companies, and the flow cytometry core facilities that support them.